Patritumab deruxtecan (ADC)
Patritumab deruxtecan is an ADC consisting of a HER3-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of non-small cell lung cancer.
Product Specifications
Product Name Alternative
HER3-DXd, U3-1287
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
041475-PE 200 µL
SCUBE2, ID (N266) (SCUBE2, CEGP1, Signal peptide, CUB and EGF-like domain-containing protein 2, Protein CEGP1) (PE) discontinued
Ask
View Details 
